4 | Radioisotopes (Radionuclides)IBA
04/2010
-
04/2007 |
3 | human ERBB2 proteinIBA
08/2017
-
06/2010 |
3 | ErbB Receptors (EGF Receptor)IBA
01/2016
-
07/2010 |
3 | Trastuzumab (Herceptin)FDA Link
07/2010
-
03/2007 |
3 | Chelating AgentsIBA
12/2008
-
11/2007 |
2 | eprenetapoptIBA
04/2023
-
12/2022 |
2 | ABY-025IBA
08/2017
-
01/2016 |
1 | Monoclonal AntibodiesIBA
01/2023 |
1 | Interleukin-17 (Interleukin 17)IBA
01/2023 |
1 | InterleukinsIBA
01/2023 |
1 | Azacitidine (5 Azacytidine)FDA Link
12/2022 |
1 | Peptides (Polypeptides)IBA
01/2016 |
1 | 68Ga-ABY-025IBA
01/2016 |
1 | Aligeron (AS 2)IBA
06/2010 |
1 | Lysine (L-Lysine)FDA Link
12/2008 |
1 | IndiumIBA
11/2007 |
1 | GalliumIBA
11/2007 |
1 | Serine (L-Serine)FDA Link
11/2007 |
1 | mercaptoacetyl-Glu-Glu-GluIBA
11/2007 |
1 | Gallium-68IBA
04/2007 |
1 | AntigensIBA
04/2007 |
1 | Indium-111IBA
04/2007 |
1 | N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA
03/2007 |
1 | Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2007 |
1 | LigandsIBA
03/2007 |
1 | tanespimycin (17AAG)IBA
03/2007 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2007 |
1 | RadiopharmaceuticalsIBA
03/2007 |
1 | 111In-benzyl-DTPA-ZHER2:342IBA
05/2006 |
1 | DNA (Deoxyribonucleic Acid)IBA
03/2006 |
1 | Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
08/2005 |
1 | Protein Isoforms (Isoforms)IBA
08/2005 |
1 | Immunoglobulins (Immunoglobulin)IBA
07/2005 |
1 | OligonucleotidesIBA
01/2002 |